Environmental and genetic factors influence the relationship between circulating il-10 and obesity phenotypes

Obesity

Volumn 18, Issue 3, 2010, Pages 611-618

  Bassols, Judit ^a   Botas, Patricia ^b   Moreno Navarrete, Jose M ^a   Delgado, Elias ^b   Ortega, Francisco ^a   Ricart, Wifredo ^a   Fernandez Real, Jose M ^b  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; ENTEROVIRUS INFECTION; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; HUMAN ADENOVIRUS INFECTION; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADENOVIRUS INFECTIONS, HUMAN; ADULT; BLOOD PRESSURE; BODY MASS INDEX; ENTEROVIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-10; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTORS, INTERLEUKIN-10; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

ADENOVIRIDAE; ENTEROVIRUS;

EID: 77249171691     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.313     Document Type: Article

References (43)

1. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-823.
2. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003;24:278-301.
3. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
4. Mendall MA, Patel P, Asante M et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-277.
5. Ziccardi P, Nappo F, Giugliano G et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809.
6. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
7. Moore KW, O'Garra A, de Waal, Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993;11:165-190.
8. Moore KW, de Waal, Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
9. Pestka S, Krause CD, Sarkar D et al. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-979.
10. Autschbach F, Braunstein J, Helmke B et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998;153:121-130.
11. Pinderski Oslund LJ, Hedrick CC, Olvera T et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 1999;19:2847-2853.
12. Shibata M, Endo S, Inada K et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 1997;17:145-150.
13. Esposito K, Pontillo A, Giugliano F et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab 2003;88:1055-1058.
14. Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M. Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 2005;28: 2036-2037.
15. van Exel E, Gussekloo J, de Craen AJ et al. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002;33:1135-1138.
16. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004;145:2273-2282.
17. Juge-Aubry CE, Somm E, Pernin A et al. Adipose tissue is a regulated source of interleukin-10. Cytokine 2005;29:270-274.
18. Manigrasso MR, Ferroni P, Santilli F et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005;90:5876-5879.
19. Oberbach A, Tönjes A, Klöting N et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol 2006;154:577-585.
20. Blüher M, Fasshauer M, Tönjes A et al. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 2005;113:534-537.
21. Kohl A, Gögebakan O, Möhlig M et al. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans. Nutr Res 2009;29:248-254.
22. Lim S, Crawley E, Woo P, Barnes PJ. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998;352:113.
23. Edwards-Smith CJ, Jonsson JR, Purdie DM et al. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999;30:526-530.
24. Scarpelli D, Cardellini M, Andreozzi F et al. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes 2006;55:1529-1533.
25. Gasche C, Grundtner P, Zwirn P et al. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production. J Immunol 2003;170:5578-5582.
26. Atkinson RL, Dhurandhar NV, Allison DB et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005;29:281-286.
27. Dhurandhar NV, Kulkarni PR, Ajinkya SM, Sherikar AA, Atkinson RL. Association of adenovirus infection with human obesity. Obes Res 1997;5:464-469.
28. Vangipuram SD, Sheele J, Atkinson RL, Holland TC, Dhurandhar NV. A human adenovirus enhances preadipocyte differentiation. Obes Res 2004;12:770-777.
29. Vangipuram SD, Yu M, Tian J et al. Adipogenic human adenovirus-36 reduces leptin expression and secretion and increases glucose uptake by fat cells. Int J Obes (Lond) 2007;31:87-96.
30. Fernández-Real JM, Ferri MJ, Vendrell J, Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity (Silver Spring) 2007;15:245-252.
31. Esteve E, Botas P, Delgado E et al. Soluble TNF-alpha receptor 2 produced by alternative splicing is paradoxically associated with markers of liver injury. Clin Immunol 2007;123:89-94.
32. Fernández-Real JM, López-Bermejo A, Vendrell J et al. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006;29:1058-1064.
33. de Waal, Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150: 4754-4765.
34. Hofer H, Neufeld JB, Oesterreicher C et al. Bi-allelic presence of the interleukin-10 receptor 1 G330R allele is associated with cirrhosis in chronic HCV-1 infection. Genes Immun 2005;6:242-247.
35. Saito T, Ji G, Shinzawa H et al. Genetic variations in humans associated with differences in the course of hepatitis C. Biochem Biophys Res Commun 2004;317:335-341.
36. Accapezzato D, Francavilla V, Paroli M et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113:963-972.
37. Clerici M, Wynn TA, Berzofsky JA et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994;93:768-775.
38. Swaminathan S. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus. Semin Hematol 2003;40: 107-115.
39. Ejrnaes M, Filippi CM, Martinic MM et al. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 2006;203:2461-2472.
40. Filippi CM, von Herrath MG. IL-10 and the resolution of infections. J Pathol 2008;214:224-230.
41. Belkaid Y, Hoffmann K F, Mendez S et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001;194:1497-1506.
42. Moore KW, Vieira P, Fiorentino DF et al. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990;248:1230-1234.
43. Jia H, Du J, Zhu S, Ma Y, Cai H. Clinical observation of serum IL-18, IL-10 and sIL-2R levels in patients with chronic hepatitis C pre-and post antiviral treatment. Chin Med J 2003;116:605-608.